PTGX (Protagonist Therapeutics) Pangali Forward P/E

Logo korporat perusahaan Protagonist Therapeutics Inc (PTGX)

What are the growth horizons for Protagonist Therapeutics (PTGX) given its peptide platform patents and royalties from industry behemoths? The answer is provided by the company's forward P/E, where 0.00 determines the latest valuation metric. This price action reflects the dependence of drug production on the reliability of external contract manufacturing organizations (CMO). Ultimately, business stability is ensured by US R&D centers and innovations in hematology treatment.

Prakiraan rega marang bathi: Protagonist (PTGX) kanggo 04.07.2022 - 15.11.2026

Rincian analitis perusahaan Protagonist Therapeutics

Ringkesan analitik perusahaan:protagonist-inc.com
Sampel barang Protagonist Therapeutics

The forward P/E compares the current market value of Protagonist Therapeutics (PTGX) with expected net income, allowing for an assessment of the cost of one dollar of future earnings while filtering out short-term market noise. For a non-cyclical biopharmaceutical business dependent on clinical trial results, the company's forward price-to-earnings ratio becomes a key indicator of fundamental value, independent of macroeconomic recessions.

Pesaing Protagonist Therapeutics (PTGX)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|IMVT - Rega marang bathi mangsa ngarep|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Prakiraan rega marang bathi|Grifols Biemat (GRFS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Adaptive Biotechnologies|Prakiraan rega marang bathi CLDX|Pangali Forward P/E auriniapharma.com|Rega marang bathi mangsa ngarep BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Rasio prakiraan rega marang bathi|AbCellera Biologics - Pangali Forward P/E|tourmalinebio.com - Rasio kapitalisasi marang bathi mangsa ngarep|Precigen (PGEN) - Rega marang bathi mangsa ngarep|Pharming Group - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Nektar Therapeutics Inc|UPB (Upstream Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ZBIO|Pangali Forward P/E immunome.com (IMNM)|Pangali Forward P/E GOSS (gossamerbio.com)|Kapitalisasi marang proyeksi bathi KalVista Pharma (KALV)|SEPN - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Pangali Forward P/E|ATXS (Astria Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Aerovate Therapeutics - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi